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ABSTRACT
Introduction: Empyema thoracis, which is the
collection of pus in the pleural cavity, has been
experiencing an increase in incidence rate in
both adults and children. When present, it is
most often a complication of some cases of
pneumonia, but a proportion may result from
iatrogenic causes or develop without pneumo-
nia. It, therefore, constitutes a significant man-
agement challenge. In the case of bacteria
resistant to conventional antibiotics, manage-
ment of this potentially fatal complication may
be difficult and is often associated with high
morbidity and mortality (ranging from 6% to
24%). We herein report a case of empyema
thoracis caused by drug-resistant Staphylococcus
aureus in an adult female.
Case Presentation: We report the case of a
28-year-old woman of black ethnicity who pre-
sented to the outpatient department with a
3-week history of unproductive cough, sharp
right-sided chest pain, shortness of breath, and
easy fatigability. Physical examination revealed
signs of right lung consolidation, and chest
X-ray showed a massive right pleural effusion
with fluid analysis revealing of a purulent exu-
date and gram positive cocci in clusters, which
was managed with cloxacillin. Culture had
growth of multidrug-resistant S. aureus sensitive
to clindamycin. A definitive diagnosis of
empyema thoracis was made and treated with
potent antibiotics and chest tube drainage with
an initial positive outcome. There was a relapse
a week later at the follow-up visit, necessitating
further antibiotherapy and associations.
Conclusion: Empyema thoracis is a common
complication, though not always, of long-
standing pneumonia with S. aureus as one of the
main causative agents. However, the resistance
of this pathogen to conventional antibiotics
probably due to longstanding self-medication
makes management delicate/difficult, as in this
case. We, therefore, recommend aggressive
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management, combining pus draining and
intravenous anti-biotherapy, especially in this
era of growing bacterial resistance to antibiotics.
Keywords: Drug resistant; Empyema thoracis;
Staphylococcus aureus
INTRODUCTION
Empyema thoracis is a disease that despite
centuries of study, still causes significant mor-
bidity and mortality [1]. It is an infection of the
pleural space (pus accumulation) that is most
commonly a complication of pneumonia
(parapneumonic). Complicated parapneumonic
effusion or pleural empyema develops in
10–20% of outpatients with pneumonia [2].
Empyema thoracis has been traditionally cate-
gorized based on three clinical phases: exuda-
tive, fibrinopurulent, and organizing [3–5]. The
initial diagnosis is made after a thorough his-
tory and physical exam to delineate the start of
symptoms and prior antibiotic treatments. The
standard chest X-ray is usually the first radio-
graphic study obtained [2]. The management of
empyema thoracis usually depends on the
clinical phase. Multiple therapeutic options are
available for the management of empyema:
antibiotherapy, thoracentesis, closed (tube)
thoracostomy, image-guided catheter drainage,
and decortication; however, the optimal thera-
peutic management has not been elucidated
[3, 4]. Decortication is more frequently neces-
sary for anaerobic, tuberculous, staphylococcal,
and pneumococcal infections [4]. When dealing
with staphylococcal empyema, treatment
should be directed into three main channels: (1)
control of the infecting organism; (2) oblitera-
tion of the empyema space; and (3) general
supportive measures. With the emergence of an
increasing number of strains resistant to the
commonly used antibiotics, it seemed worth-
while to review our recent cases of empyema
with particular emphasis on the bacteriological
aspects [6]. Data are limited on antibiotic resis-
tance of some of the common causative organ-
isms implicated in the formation of empyema
thoracis in developing settings. Here we report
the case of empyema thoracis caused by
drug-resistant Staphylococcus aureus in an adult
female.
CASE PRESENTATION
This is the case of a 28-year-old female farmer of
black ethnicity who presented to the outpatient
department with a 3-week history of unpro-
ductive cough, sharp right-sided chest pain, and
shortness of breath, all exacerbated by mild
exertion. Symptoms were associated with low
grade fever, night sweats, weight loss, and
anorexia. She was a non-smoker, seronegative
for human immunodeficiency virus (HIV), no
history of diabetes or use of corticosteroids or
other medications with immunosuppressive
potentials, and also denied any tuberculosis
(TB) exposure. Prior to consultation she had
taken as self-medication a suboptimal dose oral
amoxicillin and cotrimoxazole.
On examination, she was conscious and had
labored breathing with a respiratory rate of 32
breaths per minute, temperature 37.5 C, heart
rate 100 beats per minute, a blood pressure of
100/60 mmHg, and oxygen saturation of 93%.
She had pink conjunctivae, anicteric sclerae,
and no central or peripheral cyanosis. Her chest
exam revealed a decreased tactile vocal fremitus
and dull percussion note on the right lung field,
decreased breath sounds on the left lung and
lower third of the right lung field with no
crackles nor muffled heart sounds. The abdom-
inal examination was normal. Her full blood
count revealed a white blood cell count of
5.9 9 103/lL), lymphocytes 3.2 9 103/lL, gran-
ulocytes 2.4 9 103/lL, mean corpuscular vol-
ume (MCV) 92 fL, mean corpuscular
hemoglobin concentration (MCHC) 32 g/dL,
hematocrit of 28.5%, hemoglobin (Hb) of 9.5 g/
dL (normochromic normocytic anemia), plate-
let count of 208 9 103/lL. Zeihl-Neilsen stain of
sputum revealed no acid fast bacilli (AFB) on
two samples. Chest X-ray showed extensive
lower lung field concave opacity suggestive of a
massive right pleural effusion (Fig. 1).
She was diagnosed of empyema thoracis and
started on empiric antibiotherapy with intra-
venous (IV) cloxacillin, metronidazole, diclofe-
nac tablets, IV normal saline, and a right
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thoracotomy was done to insert a chest tube
connected to an underwater seal drain with an
initial drainage of 2.5 L of purulent fluid, which
was sent for analysis and culture. Pleural fluid
analysis showed a purulent fluid, positive for
proteins (300 mg/dL), glucose of 25 mg/dL, dif-
ferential neutrophil and lymphocyte percent-
ages of 65% and 35%, respectively, massive
white blood cells (WBC) count per high power
field (2020/mm3), gram stain revealed the pres-
ence of gram positive cocci in clusters. Lactate
dehydrogenase (LDH) and pH of the pleural
fluid weren’t analyzed by the laboratory. The
chest tube was left in situ with lavage of pleural
cavity with normal saline 0.9% on alternate days
and was well safeguarded to avoid an iatrogenic
pneumothorax or subcutaneous emphysema
and fluid in the drainage can was monitor 24
hourly and discarded (similar to pleural irriga-
tion trial by Hooper et al. though not exactly the
same) [7]. On day 3 of admission, pus culture
showed significant growth of multidrug-resis-
tant S. aureus resistant to cloxacillin, but sensi-
tive to clindamycin, vancomycin, and
ciprofloxacin leading to a switch of the IV
cloxacillin to oral clindamycin. The chest tube
was removed on the seventh day of admission
when drainage was no longer significant, and a
control X-ray showed marked reduction of
pleural effusion (Fig. 2). She was discharged on
the eighth day after chest tube removal on oral
amoxicillin plus clavulanic acid, clindamycin,
metronidazole, and diclofenac.
A week later she came for follow-up still
complaining of right-sided chest pain and
shortness of breath, and another control X-ray
showed mild to moderate pleural effusion,
which again showed gram positive cocci in
clusters on analysis. She was given 1.2 g of
cefuroxime given IV for 5 days, asked to con-
tinue with her ongoing medication, and given
another appointment in a week’s time, but she
didn’t show up.
Informed consent was obtained from the
patient for publication of this case report and
any accompanying images. All procedures fol-
lowed were in accordance with the ethical
standards of the responsible committee on
human experimentation (institutional and
national) and with the Helsinki Declaration of
1964, as revised in 2013.
DISCUSSION
Empyema, which is pus accumulation in the
pleural cavity has a three-stage natural history:
the exudative, fibrinopurulent (stage of
empyema thoracis), and organizing phases [8].
Empyema may originate from parapneumonic
pleural effusion (stage-I usually present for 1 to
Fig. 1 Chest X-ray showing massive right pleural effusion
Fig. 2 Control chest X-ray showing reduction of pleural
effusion
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3 days) when fluid may still be sterile with low
leukocyte count (\50%), low LDH levels, with a
pH in normal physiological range, and usually
normal glucose levels. If not treated early with
appropriate antibiotics it may progress to
stage-II (fibropurulent, i.e., last 4–14 days) with
high leukocytes, high LDH, low pH (\7), and
low glucose, which the most likely stage of this
patient, but couldn’t be confirmed 100% due to
lack of LDH and pH in the pleural fluid analysis
result. If still not treated with antibiotics or
fibrinolytics and intercostal drainage (closed
tube thoracostomy), as in the management of
this case, it may progress to organizational
stage; stage-III usually occurs beyond 14 days,
with extensive fibrositic activity and fibrin
deposition, with loculation and septation. Pus
formation under pressure may track its way to
adjacent structures or to the chest wall [9].
Empyemas develop primarily because of
delayed presentation by the patient with
advanced pneumonia and progressive pleural
infection as was the case in this patient and less
often, from inappropriate clinical management.
Early antibiotic treatment prevents progression
of pneumonia to parapneumonic pleural effu-
sion (PPE) and thus to empyema [10]. In our
patient, delayed presentation was due to
self-medication of an inappropriate dose of
over-the-counter antibiotherapy, which is
readily available in Cameroon and is known to
be one of the main drivers of the antibiotic
resistance pandemic [11].
In most series of patients with community
acquired empyema, aerobic bacteria predomi-
nate. These include Streptococcus pneumoniae
and S. aureus (commonest cause of empyema,
which was the micro-organism identified in this
case) often easily treatable with adequate
antibiotherapy. Aerobic organisms also include
gram negative bacteria such as Escherichia coli,
Haemophilus influenza, and Klebsiella pneumoniae
[12]. Mixed aerobic and anaerobic bacteria are
commonly isolated from empyema. The com-
monest anaerobes are Bacteroides fragilis [13].
The symptoms of pneumonia involving a
PPE or empyema (i.e., fever, malaise, cough,
dyspnea, and pleuritic chest pain) are similar to
those of pneumonia without a PPE. Our patient
probably had pneumonia due to inappropriate
treatment that progressed to pneumonia with
PPE. Elderly patients may be relatively asymp-
tomatic, presenting only with fatigue or altered
mental status, without pulmonary symptoms,
making suspicion and diagnosis relatively more
difficult in such situations. However, that was
not the situation in this patient since she was 28
years old. Other factors, such as age, peak tem-
perature, leukocyte count, or number of lobes
involved, cannot predict the presence of a PPE
or differentiate between persons with and per-
sons without a PPE. The clinical examination of
empyema patients often reveals stony dull per-
cussion note, diminished or absent air entry in
the lung, diminished tactile vocal fremitus, and
vocal resonance of the lung, as was the case in
this patient. Empyema patients usually repre-
sent a neglected pleural infection. Patients who
are hospitalized with a PPE and who receive
appropriate antibiotic treatment rarely (\2%)
develop empyema [14].
Laboratory Investigations used in the diag-
nosis of empyema thoracis include the follow-
ing. Chest X-rays and/or computerize
tomography (CT) scans (very scarce in Camer-
oon and wasn’t done in this patient) that will
show whether or not there’s fluid in the pleural
space, as in this case. An ultrasound of the chest
is used to see the amount of fluid and its exact
location. Blood tests are used to check for white
blood cell count and C-reactive protein and to
identify the particular bacteria causing the
infection. White cell count is usually elevated
when you have an infection. But this patient
had a normal white cell count, which could
suggest a decreased immune reaction to the
longstanding infection. On the other hand this
patient had a normochromic normocytic ane-
mia, which supports the possibility of chronic
inflammation in a longstanding infection.
There was no reported history of menstruation
or blood loss from other sources at the time of
presentation to us. Other investigations such as
sputum analysis by Ziehl-Neelson stain for AFB
and gram stain or blood culture can also be
done to identify causative organisms. During a
thoracentesis, a needle is inserted through the
back of the rib cage into the pleural space to
take a sample of fluid for analysis and culture.
Fluid analysis under a microscope looks for
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bacteria, protein, and other cells, as seen in this
patient [15]. We ensured that the thoracocen-
tesis to collect pleural fluid was done before
initiating antibiotics, which if done otherwise
could alter our results [16].
Treatment is aimed at removing the pus,
draining the fluid from the pleural space (closed
tube thoracostomy and treating the infection).
Antibiotics are used to treat the underlying
infection. The specific type of antibiotic
depends on what type of bacteria is causing the
infection. A culture of the collected fluid is
ideally done to confirm the sensitivity of the
causative pathogens to specific antibiotics.
Given the acute presentation in our patient, we
started the patient immediately on antibiotics
while waiting for the culture results. The S.
aureus isolated in this case by culture was resis-
tant to multiple antibiotics. Drug resistance is a
growing public health problem with potential
ramification on the cost of health care, espe-
cially in low resource settings such as Cameroon
where infectious diseases are still a significant
cause of morbidity and mortality. Resistance in
this case could be explained by the fact that the
patient had taken several over-the-counter
antibiotics before coming to the hospital. The
culture results obtained on day 3 of admission
identified S. aureus resistant to cloxacillin and
an array of antibiotics and sensitive to clin-
damycin. We then decided to switch the clox-
acillin to clindamycin oral, but 1 week after she
was discharged, symptoms relapsed despite
treatment with clindamycin.
The next step is to drain the pus, and the
specific method of pleural fluid drainage
depends on the stage of the empyema. In
simple empyema, a needle can be inserted
into the pleural space to drain the fluid. This
is called percutaneous thoracentesis [15]. In
the later stages (complex empyema), a drai-
nage tube must be used to drain the pus
(closed tube thoracotomy). This procedure is
usually performed under anesthesia in an
operating room. We, therefore, performed a
closed-tube thoracotomy in our case, given
the fact that the effusion was massive and the
draining was to be done progressively over
hours to days.
More modern techniques such as video-as-
sisted thoracic surgery (VATS) permits us to
remove the affected tissue around the lung and
insert a drainage tube or use medication to
remove the fluid. However, given the limited
array of facilities/equipment in our setting we
could not perform VATS.
CONCLUSION
Empyema thoracis should be suspected in
patients with longstanding pneumonia or
pneumonia unresponsive to appropriate
antibiotherapy. A chest radiograph (X-ray and/
or CT scan) should be done to make the diag-
nosis. Complementary investigations such as
ultrasound scan could be done to quantify the
amount of fluid in the intrapleural space, as well
as a pleural fluid analysis and culture is essential
to identify causative organisms in order to plan
appropriate treatment though there may be
multi-drug resistance by some organisms like in
this case. Thus, prompt recognition and timely
management of pneumonia will prevent devel-
opment of parapneumonic pleural effusion and
thus empyema thoracis.
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